Dr James Field, Founder & CEO
James is founder and CEO of LabGenius. James completed his PhD studies at Imperial College London where his research was focused on re-engineering protein nanocages for biotechnological applications. Prior to his PhD, James completed a BSc in Biology with Microbiology and an MRes in Systems and Synthetic Biology, at Imperial College London. James is an active member of the synthetic biology community having participated in the iGEM competition both as an undergraduate (2009), advisor (2011) and judge (2016). In 2017, James was awarded the BBSRC Innovator of the Year award for early career impact. James is also a fellow of the prestigious Synthetic Biology Leadership Excellence Accelerator Program (LEAP).
Dr Adam Russell, Business Development Officer
Commercial lead at LabGenius with responsibility for Strategy, Business Development, Market Evaluation, Commercial Partnerships and Product Management.
Adam studied Chemistry (MSci) at Imperial College where he graduated top of his year; he subsequently completed his PhD at the University of Oxford. Before joining LabGenius Adam spent several years working at Johnson Matthey (UK FTSE 100 company) where he was part of the JM Group Innovation and New Business Development team.
Harry Rickerby, Chief Scientific Officer
Harry achieved a distinction in an MRes in Systems and Synthetic Biology at Imperial College London in 2014 with a project centred around the characterisation of genetic control elements to simplify genetic circuit design and modelling. This work included the use of a cutting-edge robotic characterisation platform and high-throughput data analysis techniques. Harry has also completed a BSc in Biology from Imperial before joining LabGenius.
Dr Pedro Tizei, Automation Scientist
Pedro did his PhD studies in Structural and Molecular Biology at UCL, where he developed a novel strategy for the directed evolution of flexible loops in proteins. His broad-ranging interests eventually led him to the field of synthetic biology and his current role in optimising the biomolecule engineering platform at LabGenius. Before his PhD, Pedro was involved in research into yeast strains used in industrial bioethanol fermentation in Brazil during his MSc in Genetics and Molecular Biology at UNICAMP and received a BSc in Biological Sciences from USP.
Dr Annelie Oswald, Scientist
Annelie completed her PhD in Biology at the Max Planck Institute of Molecular Cell Biology and Genetics in early 2014. Her research focused on the reconstruction of a developmental clock using synthetic biology, high resolution imaging and microfluidics. She is enthusiastic about design driven product development that integrates DNA, protein and material science technologies with mathematical modeling and automation strategies. Annelie previously received her MSc in Molecular Bioengineering from the BIOTEC/TU-Dresden in Germany and a BSc in Biochemical Engineering from Rutgers University in NJ, USA.
Dr Ben Mackrow, Scientist
Ben completed his PhD in Synthetic Biology at Imperial College London in early 2016. His research focused on the directed evolution of target proteins to engineer both novel and improved functionality. He has a keen interest in DNA assembly and was heavily involved in the design, optimisation and automation of a novel assembly protocol. Ben previously received his MRes in Synthetic Biology (Distinction) from University College London and his BSc in Biomedical Science/Forensics from Brunel University
Mo Niknafs, Engineer
Mo completed his MEng in Mechanical Engineering at Imperial College London in 2015. For his Masters level project Mo investigated biofunctionality, focussing on the synthesis of a polydopamine-adhered antimicrobial coating (1st Class). His 3rd year group project entailed the creation of a 3D food printer, also achieving a 1st Class. Outside of academic pursuits, Mo co-founded Imperial College Design Collective and was a founding committee member of Imperial Create Lab.